Off-pump versus on-pump coronary artery surgery.

The aim of this preliminary, prospective, randomized study was to compare rotation thromboelastography (roTEG) results and D-dimer levels in off-pump versus on-pump coronary surgery in order to identify the activation of fibrinolysis. Twenty patients scheduled for coronary bypass grafting were assessed (off-pump group A, n = 10; on-pump group B, n = 10). Blood samples for roTEG examination were taken preoperatively (t0), 15 minutes after sternotomy (t1), on the completion of peripheral bypass anastomoses (t2), and at the end of procedures (t3). The time points for D-dimer levels analyses were before operation, at the end of procedures, and 24 hours later. A certain degree of roTEG signs of fibrinolysis was noticed at time t2 in both groups and in group B these marks were quite widely, but not significantly expressed (P for intergroup differences for Lysis on Set Time at 60 and 150 minutes were P = 0.190 and P = 0.122, respectively), borderline differences were found for Maximum Clot Firmness (P = 0.082) with a lower mean value for group B (arithmetic means [95% confidence intervals]--57.7 [54.2; 61.2] mm). Completely expressed roTEG signs of hyperfibrinolysis were observed in 2 patients from group B. In group B also the highest geometric means of D-dimers (1326.0 [943.5; 1863.6] ng mL(-1)) and thus a dramatic intergroup difference (P < 0.001) were observed at the end of surgery; 24 hours later the significantly elevated D-dimer levels in both groups (A: 1070.0 [723.5; 1582.6] versus B: 1093.3 [732.0; 1632.9] ng mL(-1)) were equalized (P = 0.932). Our roTEG results display a slightly greater, but fairly subtle activation of fibrinolysis during the course of cardiopulmonary bypass, compared to off-pump cardiac surgery.

[1]  Keyvan Karkouti,et al.  A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.

[2]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[3]  Z. Straka,et al.  Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  J. Vaage,et al.  Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study. , 2005, The Annals of thoracic surgery.

[5]  C D Deakin,et al.  Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. , 2005, British journal of anaesthesia.

[6]  A. Bengtsson,et al.  A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. , 2004, The Annals of thoracic surgery.

[7]  T. Treasure,et al.  Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.

[8]  J. Andreasen,et al.  Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  O. Alfieri,et al.  Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. , 2004, The Journal of thoracic and cardiovascular surgery.

[10]  H. Wendel,et al.  Hemocompatibility of PMEA Coated Oxygenators Used for Extracorporeal Circulation Procedures , 2004, ASAIO journal.

[11]  T. Carrel,et al.  Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results. , 2004, The Annals of thoracic surgery.

[12]  L. Menicanti,et al.  Reduced Systemic Heparin Dose with Phosphorylcholine Coated Closed Circuit in Coronary Operations , 2004, The International journal of artificial organs.

[13]  K. Eishi,et al.  Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). , 2004, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[14]  P. Widimsky,et al.  Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4. , 2004, The Annals of thoracic surgery.

[15]  D. W. Fried,et al.  Off-pump coronary artery bypass surgery may produce a hypercoagulable patient. , 2005, The heart surgery forum.

[16]  E. Tremoli,et al.  Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[17]  Z. Straka,et al.  Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. , 2003, The Journal of cardiovascular surgery.

[18]  Z. Straka,et al.  Less invasive cardiac anesthesia: an ultra-fast-track procedure avoiding thoracic epidural analgesia. , 2003, The heart surgery forum.

[19]  R. Hetzer,et al.  Hemostatic Activation and Inflammatory Response during Cardiopulmonary Bypass: Impact of Heparin Management , 2002, Anesthesiology.

[20]  T. Carrel,et al.  Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  O. Alfieri,et al.  Activation of Coagulation and Fibrinolysis during Coronary Surgery: On-pump versus Off-pump Techniques , 2001, Anesthesiology.

[22]  O. Alfieri,et al.  Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study. , 2001, The Annals of thoracic surgery.

[23]  C. Whitten,et al.  Thromboelastography: past, present, and future. , 2000, Anesthesiology.

[24]  D. Warner Isoflurane neuroprotection: a passing fantasy, again? , 2000, Anesthesiology.

[25]  M. Horáček,et al.  A retrospective survey of fibrinolysis as an indicator of poor outcome after cardiopulmonary bypass and a possible early sign of systemic inflammation syndrome. , 2000, European journal of anaesthesiology.

[26]  G. Dhonneur,et al.  Effects of overnight work on doctors' daytime activity: , 2000 .

[27]  M. Prins,et al.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.

[28]  W. van Oeveren,et al.  Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? , 1999, The Annals of thoracic surgery.

[29]  R. Colman,et al.  Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. , 1996, Circulation.

[30]  L. Mannucci,et al.  One Month Follow-up of Haemostatic Variables in Patients Undergoing Aortocoronary Bypass Surgery , 1995, Thrombosis and Haemostasis.